Sprint fidelis lead fractures in patients with cardiac resynchronization therapy devices: Insight from the resynchronization/defibrillation for ambulatory heart failure (RAFT) study

Circulation

Volumn 126, Issue 25, 2012, Pages 2928-2934

  Parkash, Ratika ^a   Thibault, Bernard ^b   Sterns, Larry ^c   Sapp, John ^a   Krahn, Andrew ^c   Talajic, Mario ^b   Luce, Marilynn ^d   Yetisir, Elizabeth ^d   Theoret Patrick, Patricia ^d   Wells, George ^d   Tang, Anthony ^c  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

cardiac resynchronization; complications; defibrillation; heart failure; implantable cardioverter defibrillators; pacing

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; ELECTROGRAPHY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; LEAD FRACTURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS FAILURE;

AGED; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED;

EID: 84871344586     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.132100     Document Type: Article

References (16)

1. Medtronic Inc. Urgent Medical Device Information: Sprint Fidelis Lead Patient Management Recommendations. October 15, 2007. http://www.medtronic.com/ product-advisories/physician/sprint-fidelis/PROD-ADV-PHYS-OCT. Accessed October 1, 2012.
2. Farwell D, Green MS, Lemery R, Gollob MH, Birnie DH. Accelerating risk of Fidelis lead fracture. Heart Rhythm. 2008;5:1375-1379.
3. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6:605-610.
4. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter- defibrillator leads. Circulation. 2008;118:2122-2129.
5. Catanchin A, Anderson L, Jones S, Ward D. The higher than expected early failure rate of the Sprint Fidelis implantable cardioverter defi-brillator lead (model 6949, Medtronic, Inc.). Heart Rhythm. 2008;5: 167-168.
6. Krahn AD, Champagne J, Healey JS, Cameron D, Simpson CS, Thibault B, Mangat I, Tung S, Sterns L, Birnie DH, Exner DV, Parkash R, Sivakumaran S, Davies T, Coutu B, Crystal E, Wolfe K, Verma A, Stephenson E, Sanatani S, Gow R, Connors S, Paredes FA, Essebag V. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2008;5:639-642.
7. Parkash R, Crystal E, Bashir J, Simpson C, Birnie D, Sterns L, Exner D, Thibault B, Connors S, Healey JS, Champagne J, Cameron D, Mangat I, Verma A, Wolfe K, Essebag V, Kus T, Ayala-Paredes F, Davies T, Sanatani S, Gow R, Coutu B, Sivakumaran S, Stephenson E, Krahn A. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation. 2010;121:2384-2387.
8. Maytin M, Love CJ, Fischer A, Carrillo RG, Garisto JD, Bongiorni MG, Segreti L, John RM, Michaud GF, Albert CM, Epstein LM. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. J Am Coll Cardiol. 2010;56:646-650.
9. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-2395.
10. Tang AS, Wells GA, Arnold M, Connolly S, Hohnloser S, Nichol G, Rouleau J, Sheldon R, Talajic M. Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design. Curr Opin Cardiol. 2009;24:1-8.
11. Hauser RG, Maisel WH, Friedman PA, Kallinen LM, Mugglin AS, Kumar K, Hodge DO, Morrison TB, Hayes DL. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management. Circulation. 2011;123: 358-363.
12. Morrison TB, Rea RF, Hodge DO, Crusan D, Koestler C, Asirvatham SJ, Bradley D, Shen WK, Munger TM, Hammill SC, Friedman PA. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead. J Cardiovasc Electrophysiol. 2010;21:671-677.
13. Ha AC, Vezi BZ, Keren A, Alanazi H, Gollob MH, Green MS, Lemer R, Nery PB, Posan E, Birnie DH. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead. Pacing Clin Electrophysiol. 2010;33:437-443.
14. Swerdlow C, Sachanandani H, Gunderson BD, Ousdigian KT, Ellenbogen KA. Ventricular pacing-induced oversensing in ICD lead fractures. Heart Rhythm. 2011;8:S117.
15. Morrison TB, Friedman PA, Kallinen LM, Hodge DO, Crusan D, Kumar K, Hayes DL, Rea RF, Hauser RG. Impact of implanted recalled Sprint Fidelis lead on patient mortality. J Am Coll Cardiol. 2011;58:278-283.
16. Birnie DH, Parkash R, Exner DV, Essebag V, Healey JS, Verma A, Coutu B, Kus T, Mangat I, Ayala-Paredes F, Nery P, Wells G, Krahn AD. Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee. Circulation. 2012;125:1217-25.